vs
Side-by-side financial comparison of Community West Bancshares (CWBC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $38.3M, roughly 1.0× Community West Bancshares). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $43.6M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs -15.0%).
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CWBC vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $39.6M |
| Net Profit | — | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 40.0% | 32.5% |
| Net Margin | — | 35.9% |
| Revenue YoY | 11.6% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $0.58 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $39.6M | ||
| Q3 25 | $37.9M | $43.4M | ||
| Q2 25 | $35.7M | $43.4M | ||
| Q1 25 | $34.8M | $47.3M | ||
| Q4 24 | $34.3M | $44.4M | ||
| Q3 24 | $31.3M | $53.1M | ||
| Q2 24 | $30.5M | $53.1M | ||
| Q1 24 | $20.7M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $10.9M | $12.8M | ||
| Q2 25 | $7.8M | $2.5M | ||
| Q1 25 | $8.3M | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $3.4M | $2.8M | ||
| Q2 24 | $-6.3M | $18.5M | ||
| Q1 24 | $3.7M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 40.0% | 32.5% | ||
| Q3 25 | 39.8% | 36.6% | ||
| Q2 25 | 30.2% | 33.6% | ||
| Q1 25 | 32.7% | 51.1% | ||
| Q4 24 | 31.0% | 10.6% | ||
| Q3 24 | 13.3% | 26.1% | ||
| Q2 24 | -25.9% | 51.4% | ||
| Q1 24 | 23.2% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | 28.7% | 29.6% | ||
| Q2 25 | 22.0% | 5.7% | ||
| Q1 25 | 23.8% | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 10.8% | 5.3% | ||
| Q2 24 | -20.7% | 34.8% | ||
| Q1 24 | 17.8% | 34.2% |
| Q4 25 | $0.58 | $0.15 | ||
| Q3 25 | $0.57 | $0.12 | ||
| Q2 25 | $0.41 | $0.02 | ||
| Q1 25 | $0.44 | $0.21 | ||
| Q4 24 | $0.29 | $0.05 | ||
| Q3 24 | $0.18 | $0.03 | ||
| Q2 24 | $-0.33 | $0.20 | ||
| Q1 24 | $0.31 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $119.0M | $164.1M |
| Total DebtLower is stronger | $69.5M | $42.8M |
| Stockholders' EquityBook value | $409.6M | $248.3M |
| Total Assets | $3.7B | $380.4M |
| Debt / EquityLower = less leverage | 0.17× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.0M | $164.1M | ||
| Q3 25 | $121.6M | $127.4M | ||
| Q2 25 | $134.4M | $152.7M | ||
| Q1 25 | $148.4M | $132.1M | ||
| Q4 24 | $120.4M | $125.0M | ||
| Q3 24 | $149.0M | $137.4M | ||
| Q2 24 | $109.7M | — | ||
| Q1 24 | $61.0M | — |
| Q4 25 | $69.5M | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | $69.9M | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $409.6M | $248.3M | ||
| Q3 25 | $397.6M | $248.0M | ||
| Q2 25 | $380.0M | $244.6M | ||
| Q1 25 | $372.2M | $226.4M | ||
| Q4 24 | $362.7M | $195.1M | ||
| Q3 24 | $363.5M | $205.0M | ||
| Q2 24 | $350.2M | $8.8M | ||
| Q1 24 | $211.7M | $9.0M |
| Q4 25 | $3.7B | $380.4M | ||
| Q3 25 | $3.6B | $321.4M | ||
| Q2 25 | $3.6B | $315.3M | ||
| Q1 25 | $3.6B | $284.6M | ||
| Q4 24 | $3.5B | $266.1M | ||
| Q3 24 | $3.5B | $296.5M | ||
| Q2 24 | $3.5B | $19.5M | ||
| Q1 24 | $2.4B | $19.8M |
| Q4 25 | 0.17× | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | 0.19× | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.1M | $52.0M |
| Free Cash FlowOCF − Capex | $43.6M | $51.2M |
| FCF MarginFCF / Revenue | 113.9% | 129.3% |
| Capex IntensityCapex / Revenue | 6.6% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $77.7M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.1M | $52.0M | ||
| Q3 25 | $13.2M | $-20.9M | ||
| Q2 25 | $11.5M | $-8.3M | ||
| Q1 25 | $11.1M | $1.9M | ||
| Q4 24 | $22.2M | $-7.3M | ||
| Q3 24 | $7.8M | $5.0M | ||
| Q2 24 | $5.2M | $19.2M | ||
| Q1 24 | $4.0M | $3.7M |
| Q4 25 | $43.6M | $51.2M | ||
| Q3 25 | $12.8M | $-20.9M | ||
| Q2 25 | $10.6M | $-8.6M | ||
| Q1 25 | $10.8M | $1.7M | ||
| Q4 24 | $17.2M | $-7.9M | ||
| Q3 24 | $5.2M | $4.6M | ||
| Q2 24 | $4.8M | $18.3M | ||
| Q1 24 | $3.6M | $3.0M |
| Q4 25 | 113.9% | 129.3% | ||
| Q3 25 | 33.7% | -48.3% | ||
| Q2 25 | 29.6% | -19.9% | ||
| Q1 25 | 30.9% | 3.5% | ||
| Q4 24 | 50.0% | -17.8% | ||
| Q3 24 | 16.7% | 8.7% | ||
| Q2 24 | 15.7% | 34.5% | ||
| Q1 24 | 17.3% | 5.4% |
| Q4 25 | 6.6% | 2.0% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | 2.7% | 0.7% | ||
| Q1 25 | 0.9% | 0.5% | ||
| Q4 24 | 14.7% | 1.3% | ||
| Q3 24 | 8.1% | 0.8% | ||
| Q2 24 | 1.4% | 1.6% | ||
| Q1 24 | 2.1% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | 1.21× | -1.63× | ||
| Q2 25 | 1.47× | -3.39× | ||
| Q1 25 | 1.33× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 2.29× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | 1.09× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CWBC
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
